Reading time is 2 mins
.
.
BIG CONCERN IN CORONA VIRUS VACCINE
Emergent BioSolutions, which produces the Covid-19 vaccine developed by Johnson & Johnson in Baltimore, USA, has disrupted the vaccine process in Europe, South Africa and Canada due to manufacturing errors and quality control problems.
Emergent BioSolutions, which produces Johnson & Johnson’s vaccines in Baltimore, USA, is experiencing a problem in the field of quality control, on the agenda of the international public…
First reported by the New York Times, It was announced that quality control problems in the production process of Emergent BioSolutions had negatively affected the vaccination process in Europe, South Africa and Canada.
.
THESE VACCINES ARE BEING SENT TO OTHER COUNTRIES
The distribution of millions of Johnson & Johnson vaccines has been stopped in all three regions, while the vaccines produced at this plant have not received approval from the Food and Drug Administration, a major U.S. Health Organization. U.S. President Joe Biden has also said in the past that Johnson & Johnson vaccines produced at this plant are not used in the country and that these vaccines are imported.
But because of this safety weakness, millions of doses were found to be waiting in Canada, the European Union and South Africa. In March, it was revealed that Johnson & Johnson’s vaccine at the factory in Baltimore had been added to harmless viruses used in the production of AstraZeneca’s vaccine, and 15 million doses of the vaccine had been trashed in the wake of this crisis.
.
BIG PROBLEM IN SOUTH AFRICA
“We have examined some samples of the vaccine produced at Emergent and we do not see a problem,” EU officials said, while Canadian and South African officials, along with EU officials, said there was no indication that the vaccines they had were damaged or damaged. But officials also announced that the vaccines had been put on hold.
But the U.S. Food and Drug Administration (FDA) also said that reviews are continuing for about 70 million doses to be used inside the United States, and that these vaccines may not be good enough to be used in the United States. Speaking to the New York Times, an FDA spokesperson said, “We are currently in contact with foreign agencies and organizations and are examining the situation. Other countries import medicines and vaccines according to their own standards,” he said.
Johnson & Johnson’s vaccine crisis is going to be a big problem in a country like South Africa that is experiencing a vaccine crisis and has a low vaccination rate across the community, or in countries like Canada that put a four-month period between two-dose vaccines.
.
.
.
- CRANIOCERVICAL SYNDROME MISALIGNMENT IN THE UPPER CERVICAL REGION - 16/04/2024
- MISALIGNMENT OF THE UPPER CERVICAL BONES (C1-C2) - 16/04/2024
- WHAT IS GLOSSOPHARYNGEAL NEURALGIA (SORE THROAT)? - 16/04/2024